Physician profile
Keith B Hall
NPI 1932163177
$30,076.57
in general payments reported to CMS, 2019-2025
31 companies · $6,551 in 2025
The $6,551 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $126 · 2021: $223 · 2022: $232 · 2023: $12K · 2024: $11K · 2025: $6,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $28K · Food and Beverage: $958 · Travel and Lodging: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $27,750.45 |
| Food and Beverage | $957.80 |
| Travel and Lodging | $482.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $27,785.92 | 2023-2025 | Djo Surgical |
| Linvatec Corporation | $605.71 | 2024 | Biobrace 23mm, Livatec Knee Preservation System, Linvatec Shoulder Arthroscopy |
| Smith+Nephew, INC. | $177.72 | 2023-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $166.23 | 2019-2025 | Juggerknotless Soft Anchor, Tapestry |
| Amgen INC. | $155.59 | 2019-2023 | Prolia, Evenity |
| Depuy Synthes Sales INC. | $134.55 | 2019-2023 | Rigidloop |
| Stryker Corporation | $119.95 | 2021-2023 | Crossfire |
| Anika Therapeutics, INC. | $105.57 | 2024 | Integrity, Tactoset, Ovomotion |
| Medtronic, INC. | $90.28 | 2021-2022 | |
| Pacira Therapeutics, INC. | $70.95 | 2019 | |
| Ferring Pharmaceuticals INC. | $61.65 | 2022-2024 | Euflexxa |
| Acacia Pharma INC | $59.20 | 2022 | |
| Fusion Orthopedics USA, LLC | $59.00 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $54.01 | 2022-2024 | Exparel, Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $42.61 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $40.41 | 2019-2025 | |
| Conmed Corporation | $39.20 | 2021 | |
| Heron Therapeutics, INC. | $39.07 | 2021-2024 | Zynrelef |
| Avanos Medical | $32.71 | 2025 | Generator |
| Biom'Up France Sas | $31.10 | 2020 | |
| Polynovo North America LLC | $28.29 | 2024 | Novosorb Btm |
| Legacy Ortho LLC | $26.32 | 2023 | |
| My01 INC. | $22.42 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Integra Lifesciences Corporation | $22.19 | 2019 | |
| Abbvie INC. | $18.98 | 2022 | |
| Baxter Healthcare | $18.37 | 2025 | Perclot |
| Orthogenrx INC. | $17.27 | 2019 | |
| Bioventus LLC | $15.32 | 2020 | |
| Csl Behring | $13.63 | 2025 | Kcentra |
| Paratek Pharmaceuticals, INC. | $12.48 | 2021 | |
| Orthofix Medical, INC. | $9.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.